Substance
RAMUCIRUMAB
Global reference: every product and company linked to this substance.
- cas: 947687-13-0
- ncit: C70792
- rxnorm: 1535922
- unii: D99YVK4L0X
1121B · CYRAMZA · IMC-1121B · LY3009806 · ramucirumab [INN] · RAMUCIRUMAB [JAN] · RAMUCIRUMAB [USAN] · Ramucirumab [WHO-DD]
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ELI LILLY AND COMPANY COMMON STOCK | CYRAMZA | Q4 2024 | $258.5M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- CYRAMZA · ELI LILLY AND COMPANY COMMON STOCK